The invention discloses a 2, 3-dihydro-3, 5-dihydroxy-6-methyl-4 (H)
pyran-4-one-
oxygen vanadium complex as well as a preparation method and application of the 2, 3-dihydro-3, 5-dihydroxy-6-methyl-4 (H)
pyran-4-one-
oxygen vanadium complex. The preparation method comprises the following steps: carrying out a reaction on glucose and
piperidine to obtain 2, 3-dihydro-3, 5-dihydroxy-6-methyl-4 (H)
pyran-4-
ketone, carrying out a reaction on 2, 3-dihydro-3, 5-dihydroxy-6-methyl-4 (H) pyran-4-
ketone and
vanadyl sulfate or
vanadyl acetylacetonate to obtain a 2, 3-dihydro-3, 5-dihydroxy-6-methyl-4 (H) pyran-4-
ketone-vanadyl complex, and carrying out a reaction on the 2, 3-dihydro-3, 5-dihydroxy-6-methyl-4 (H) pyran-4-ketone and
vanadyl sulfate or
vanadyl acetylacetonate to obtain the 2, 3-dihydro-3, 5-dihydroxy-6-methyl-4 (H) pyran-4-ketone-vanadyl complex.
Raceme and
enantiomer of the compound are shown in the specification. The obtained complex is used as a PTP1B
enzyme inhibitor to be applied to preparation of drugs for reducing
blood sugar. According to the invention, 2, 3-dihydro-3, 5-dihydroxy-6-methyl-4 (H) pyran-4-ketone with
antioxidant activity is used as a ligand to form a complex with
vanadium oxide, so that vanadium can play a role in reducing
blood sugar, and
oxidative stress can be potentially reduced through the
antioxidant activity of the ligand.